U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H21N5
Molecular Weight 295.3821
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of A-943931

SMILES

N[C@@H]1CCN(C1)C2=C3CCCC4=CC=CC=C4C3=NC(N)=N2

InChI

InChIKey=SDTRYHWIXVHTLM-GFCCVEGCSA-N
InChI=1S/C17H21N5/c18-12-8-9-22(10-12)16-14-7-3-5-11-4-1-2-6-13(11)15(14)20-17(19)21-16/h1-2,4,6,12H,3,5,7-10,18H2,(H2,19,20,21)/t12-/m1/s1

HIDE SMILES / InChI

Molecular Formula C17H21N5
Molecular Weight 295.3821
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including http://www.fasebj.org/content/23/1_Supplement/760.8.short

A-943931 is a potent and selective H4R antagonist with high affinity at both human (Kis = 4.6 nM) and rat (Kis = 3.8 nM) receptors. A-943931 competitively and potently antagonizes rat H4R agonist-mediated responses in [35S]GTPγS binding assays (Kbs = 28 nM) and intracellular calcium mobilization at rat and human receptors (Kbs from 5-10 nM). When tested in vivo in a mouse model of clobenpropit (10 nM, i.d.) induced scratching, A-943931 inhibited the scratching response (IC50 = 26 umoles/kg, i.p.) with significant inhibition (69%) at the highest tested dose (30 umoles/kg, i.p.). A-943931 is a potent and selective H4R antagonist with robust antipruritic activity and is a useful tool for further exploration of the role of H4R receptors in vivo.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

When tested in vivo in a mouse model of clobenpropit (10 nM, i.d.) induced scratching, A-943931 inhibited the scratching response (IC50 = 26 umoles/kg, i.p.) with significant inhibition (69%) at the highest tested dose (30 umoles/kg, i.p.).
Route of Administration: Intraperitoneal
A-943931 demonstrated functional antagonism in vitro in an assay of cells natively expressing H4 receptors (BMMC), with an IC50 of 0.38 uM for blockade of histamine-induced shape change
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:57:40 GMT 2023
Edited
by admin
on Sat Dec 16 10:57:40 GMT 2023
Record UNII
Q598HK01AO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
A-943931
Common Name English
5H-BENZO(6,7)CYCLOHEPTA(1,2-D)PYRIMIDIN-2-AMINE, 4-((3R)-3-AMINO-1-PYRROLIDINYL)-6,7-DIHYDRO-
Systematic Name English
Code System Code Type Description
FDA UNII
Q598HK01AO
Created by admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
PRIMARY
PUBCHEM
25068753
Created by admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
PRIMARY
CAS
1027330-97-7
Created by admin on Sat Dec 16 10:57:40 GMT 2023 , Edited by admin on Sat Dec 16 10:57:40 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY